Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
The challenge of comorbidity in clinical trials for multiple sclerosis.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
Interferon-beta(1b) treatment in neuromyelitis optica.
Visualization of myelination in GFP-transgenic zebrafish.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Information for healthcare professionals: Rituximab
Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
199 Outcomes after microvascular decompression for patients with trigeminal neuralgia and suspected multiple sclerosis.
SigmaPharm Laboratories Products
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Biomarkers for Brain Disorders: Challenges and Opportunities
Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
A randomized controlled phase II trial of riluzole in early multiple sclerosis.
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
From Bugs to Brains: the gut microbiome in neurological health

Pages